These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10325825)

  • 61. Cardiac effects of short course dexamethasone in preterm infants.
    Skelton R; Gill AB; Parsons JM
    Arch Dis Child Fetal Neonatal Ed; 1998 Mar; 78(2):F133-7. PubMed ID: 9577285
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reversible steroid-induced hypertrophic cardiomyopathy with left ventricular outflow tract obstruction in two newborns.
    Haney I; Lachance C; van Doesburg NH; Fouron JC
    Am J Perinatol; 1995 Jul; 12(4):271-4. PubMed ID: 7575834
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dexamethasone for bronchopulmonary dysplasia.
    Donn SM; Faix RG; Banagale RC
    Lancet; 1983 Aug; 2(8347):460. PubMed ID: 6135948
    [No Abstract]   [Full Text] [Related]  

  • 64. Dexamethasone therapy for bronchopulmonary dysplasia.
    Kramer LI
    Va Med Q; 1994; 121(4):239-40, 244. PubMed ID: 7948077
    [No Abstract]   [Full Text] [Related]  

  • 65. [Dexamethasone in the treatment of bronchopulmonary dysplasia].
    Schrod L; Frauendienst-Egger G; Forgber I; von Stockhausen HB
    Pneumologie; 1991 Nov; 45(11):892-6. PubMed ID: 1762998
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Catabolic effect of dexamethasone in the preterm baby.
    Brownlee KG; Ng PC; Henderson MJ; Smith M; Green JH; Dear PR
    Arch Dis Child; 1992 Jan; 67(1 Spec No):1-4. PubMed ID: 1482427
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Postnatal steroids: a dilemma for the neonatologist.
    Halliday HL
    Acta Paediatr; 2001 Feb; 90(2):116-8. PubMed ID: 11236036
    [No Abstract]   [Full Text] [Related]  

  • 68. EBNEO Commentary: Hydrocortisone to improve survival without bronchopulmonary dysplasia.
    Jakubowicz J
    Acta Paediatr; 2022 Nov; 111(11):2244-2245. PubMed ID: 36036058
    [No Abstract]   [Full Text] [Related]  

  • 69. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials.
    Onland W; Offringa M; De Jaegere AP; van Kaam AH
    Pediatrics; 2009 Jan; 123(1):367-77. PubMed ID: 19117904
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia.
    Bassler D; van den Anker J
    Pediatr Clin North Am; 2017 Dec; 64(6):1355-1367. PubMed ID: 29173790
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of beta-blockade on symptomatic dexamethasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review.
    Fritz KI; Bhat AM
    J Perinatol; 1998; 18(1):38-44. PubMed ID: 9527943
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The use of corticosteroids in bronchopulmonary dysplasia].
    Wesselink MW; van den Anker JN; Sauer PJ
    Ned Tijdschr Geneeskd; 1991 May; 135(21):943-6. PubMed ID: 2052111
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dexamethasone and bronchopulmonary dysplasia.
    Frank L; Lecuona PC
    Pediatrics; 1996 Sep; 98(3 Pt 1):514-5. PubMed ID: 8784386
    [No Abstract]   [Full Text] [Related]  

  • 74. Postnatal dexamethasone for lung disease of prematurity.
    Watchko JF; Brozanski BS
    N Engl J Med; 2004 Jun; 350(26):2715-8; author reply 2715-8. PubMed ID: 15218577
    [No Abstract]   [Full Text] [Related]  

  • 75. The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone.
    Kelly EJ; Chatfield SL; Brownlee KG; Ng PC; Newell SJ; Dear PR; Primrose JN
    Arch Dis Child; 1993 Jul; 69(1 Spec No):37-9. PubMed ID: 8346951
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cardiovascular and metabolic side effects associated with hydrocortisone and dexamethasone use in VLBW infants: a single-centre experience.
    Röhr SB; Sauer H; Gortner L; Gräber S; Meyer S
    Acta Paediatr; 2013 Oct; 102(10):e436. PubMed ID: 23819647
    [No Abstract]   [Full Text] [Related]  

  • 77. [Dexamethasone therapy in bronchopulmonary dysplasia].
    Merz U; Kuehl G; Linderkamp O
    Klin Padiatr; 1989; 201(1):11-5. PubMed ID: 2495383
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of dexamethasone and spironolactone therapy in calcium and phosphate homeostasis in premature infants with a birth weight under 1,500 g].
    Sonntag J; Gaude M
    Klin Padiatr; 1998; 210(5):354-7. PubMed ID: 9782479
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Steroid therapy and the treatment of bronchopulmonary dysplasia: an error in neonatology, or an unavoidable therapeutic intervention?
    Kaplan M
    J Perinatol; 2004 Feb; 24(2):127-8; author reply 128-9. PubMed ID: 14872210
    [No Abstract]   [Full Text] [Related]  

  • 80. Hypothalamic-pituitary-adrenal axis function in very low birth weight infants treated with dexamethasone.
    Alkalay AL; Pomerance JJ; Puri AR; Lin BJ; Vinstein AL; Neufeld ND; Klein AH
    Pediatrics; 1990 Aug; 86(2):204-10. PubMed ID: 2371095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.